TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 RESEARCH OBJECTIVE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 CONSUMPTION & NET TRADE APPROACH
3.6.2 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.1.1 INNOVATION IN DRUG FORMULATIONS AND DELIVERY SYSTEMS
4.1.2 HEALTHCARE ACCESSIBILITY AND REGULATION
4.1.3 RISING DEMAND FOR NASAL SPRAYS AND INHALERS
4.2 DRIVERS
4.2.1 INCREASING INCIDENCE OF RESPIRATORY DISEASES
4.2.2 GROWING POPULARITY OF SELF-MEDICATION
4.3 RESTRAINTS
4.3.1 STRINGENT REGULATORY GUIDELINES
4.3.2 SIDE EFFECTS AND SAFETY CONCERNS ASSOCIATED WITH DECONGESTANTS
4.4 OPPORTUNITY
4.4.1 INCREASED DEMAND FOR NATURAL AND HERBAL DECONGESTANTS
4.4.2 DEVELOPMENT OF COMBINATION THERAPIES TARGETING MULTIPLE SYMPTOMS
4.5 IMPACT ANALYSIS OF COVID-19
4.5.1 IMPACT ON OVERALL HEALTHCARE
4.5.2 IMPACT ON GLOBAL DECONGESTANT MARKET
4.5.3 IMPACT ON SUPPLY CHAIN OF GLOBAL DECONGESTANT MARKET
4.5.4 IMPACT ON MARKET DEMAND OF GLOBAL DECONGESTANT MARKET
4.5.5 IMPACT ON PRICING OF GLOBAL DECONGESTANT MARKET
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY/VALUE CHAIN ANALYSIS
5.1.1 RAW MATERIAL PROCUREMENT
5.1.2 MANUFACTURING
5.1.3 PACKAGING & LABELLING
5.1.4 DISTRIBUTION AND RETAIL
5.1.5 RETAIL & CONSUMER DEMAND
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 THREAT OF SUBSTITUTES
5.2.3 BARGAINING POWER OF SUPPLIERS
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
6 GLOBAL DECONGESTANT MARKET, BY PRODUCT TYPE
6.1 INTRODUCTION
6.1.1 SYNTHETIC DECONGESTANTS
6.1.2 AROMATIC DECONGESTANTS
6.1.3 HERBAL DECONGESTANTS
6.1.4 COMBINATION
7 GLOBAL DECONGESTANT MARKET, BY FORMULATION
7.1 INTRODUCTION
7.1.1 NASAL
7.1.1.1 NASAL SPRAY
7.1.1.2 NASAL DROPS
7.1.1.3 INHALERS
7.1.2 ORAL
7.1.2.1 TABLETS & CAPSULES
7.1.2.2 LIQUIDS & SYRUPS
7.1.3 TOPICAL
7.1.3.1 GELS
7.1.3.2 PATCHES
8 GLOBAL DECONGESTANT MARKET, BY CATEGORY
8.1 INTRODUCTION
8.1.1 PRESCRIPTION-BASED
8.1.2 OVER THE COUNTER
9 GLOBAL DECONGESTANT MARKET, BY APPLICATION
9.1 INTRODUCTION
9.1.1 NASAL ALLERGIES
9.1.2 COLD
9.1.3 ASTHMA
9.1.4 RHINITIS
9.1.5 SINUSITIS
9.1.6 NASAL POLYPS
9.1.7 OTHERS
10 GLOBAL DECONGESTANT MARKET, BY AGE GROUP
10.1 INTRODUCTION
10.1.1 PEDIATRICS
10.1.2 GERIATRICS
11 GLOBAL DECONGESTANT MARKET, BY DISTRIBUTION CHANNEL
11.1 INTRODUCTION
11.1.1 HOSPITAL PHARMACIES
11.1.2 DRUG STORES & RETAIL PHARMACIES
11.1.3 ONLINE PHARMACIES
12 GLOBAL DECONGESTANT MARKET, BY REGION
12.1 INTRODUCTION
12.1.1 NORTH AMERICA
12.1.1.1 US
12.1.1.2 CANADA
12.1.1.3 MEXICO
12.1.2 EUROPE
12.1.2.1 GERMANY
12.1.2.2 UK
12.1.2.3 FRANCE
12.1.2.4 ITALY
12.1.2.5 SPAIN
12.1.2.6 REST OF EUROPE
12.1.3 ASIA-PACIFIC
12.1.3.1 JAPAN
12.1.3.2 CHINA
12.1.3.3 INDIA
12.1.3.4 SOUTH KOREA
12.1.3.5 INDONESIA
12.1.3.6 MALAYSIA
12.1.3.7 AUSTRALIA
12.1.3.8 SINGAPORE
12.1.3.9 REST OF ASIA PACIFIC
12.1.4 SOUTH AMERICA
12.1.4.1 BRAZIL
12.1.4.2 ARGENTINA
12.1.4.3 REST OF SOUTH AMERICA
12.1.5 MIDDLE EAST & AFRICA
12.1.5.1 SOUTH AFRICA
12.1.5.2 GCC COUNTRIES
12.1.5.3 SAUDI ARABIA
12.1.5.4 REST OF MIDDLE EAST AND AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 MARKET SHARE ANALYSIS, 2024
14 COMPANY PROFILES
14.1 PFIZER.
14.1.1 COMPANY OVERVIEW
14.1.2 PRODUCTS OFFERED
14.1.3 SWOT ANALYSIS
14.1.4 KEY STRATEGY
14.2 CIPLA LTD.
14.2.1 COMPANY OVERVIEW
14.2.2 PRODUCTS OFFERED
14.2.3 SWOT ANALYSIS
14.2.4 KEY STRATEGY
14.3 GLAXOSMITHKLINE (GSK)/ PANADOL
14.3.1 COMPANY OVERVIEW
14.3.2 PRODUCTS OFFERED
14.3.3 SWOT ANALYSIS
14.3.4 KEY STRATEGY
14.4 JOHNSON & JOHNSON
14.4.1 COMPANY OVERVIEW
14.4.2 PRODUCTS OFFERED
14.4.3 SWOT ANALYSIS
14.4.4 KEY STRATEGY
14.5 APTARGROUP, INC.
14.5.1 COMPANY OVERVIEW
14.5.2 PRODUCTS OFFERED
14.5.3 SWOT ANALYSIS
14.5.4 KEY STRATEGY
14.6 PROCTOR & GAMBLE COMPANY
14.6.1 COMPANY OVERVIEW
14.6.2 PRODUCTS OFFERED
14.6.3 SWOT ANALYSIS
14.6.4 KEY STRATEGY
14.7 RECKITT BENCKISER GROUP PLC
14.7.1 COMPANY OVERVIEW
14.7.2 PRODUCTS OFFERED
14.7.3 SWOT ANALYSIS
14.7.4 KEY STRATEGY
14.8 SANOFI
14.8.1 COMPANY OVERVIEW
14.8.2 PRODUCTS OFFERED
14.8.3 SWOT ANALYSIS
14.8.4 KEY STRATEGY
14.9 PERRIGO COMPANY PLC
14.9.1 COMPANY OVERVIEW
14.9.2 PRODUCTS OFFERED
14.9.3 SWOT ANALYSIS
14.9.4 KEY STRATEGY
14.10 DR. REDDY’S LABORATORIES
14.10.1 COMPANY OVERVIEW
14.10.2 PRODUCTS OFFERED
14.10.3 SWOT ANALYSIS
14.10.4 KEY STRATEGY
15 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 3 GLOBAL DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 4 GLOBAL DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 5 GLOBAL DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 6 GLOBAL DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 7 GLOBAL DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 8 GLOBAL DECONGESTANT ESTIMATES & FORECAST, BY REGION, 2019–2035 (USD BILLION)
TABLE 9 NORTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 10 NORTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 11 NORTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 12 NORTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 13 NORTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 14 NORTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 15 US DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 16 US DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 17 US DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 18 US DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 19 US DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 20 US DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 21 CANADA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 22 CANADA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 23 CANADA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 24 CANADA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 25 CANADA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 26 CANADA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 27 MEXICO DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 28 MEXICO DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 29 MEXICO DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 30 MEXICO DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 31 MEXICO DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 32 MEXICO DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 33 EUROPE DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 34 EUROPE DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 35 EUROPE DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 36 EUROPE DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 37 EUROPE DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 38 EUROPE DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 39 GERMANY DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 40 GERMANY DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 41 GERMANY DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 42 GERMANY DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 43 GERMANY DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 44 GERMANY DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 45 UK DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 46 UK DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 47 UK DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 48 UK DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 49 UK DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 50 UK DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 51 FRANCE DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 52 FRANCE DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 53 FRANCE DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 54 FRANCE DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 55 FRANCE DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 56 FRANCE DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 57 ITALY DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 58 ITALY DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 59 ITALY DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 60 ITALY DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 61 ITALY DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 62 ITALY DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 63 SPAIN DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 64 SPAIN DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 65 SPAIN DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 66 SPAIN DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 67 SPAIN DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 68 SPAIN DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 69 REST OF EUROPE DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 70 REST OF EUROPE DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 71 REST OF EUROPE DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 72 REST OF EUROPE DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 73 REST OF EUROPE DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 74 REST OF EUROPE DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 75 ASIA-PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 76 ASIA-PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 77 ASIA-PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 78 ASIA-PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 79 ASIA-PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 80 ASIA-PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 81 JAPAN DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 82 JAPAN DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 83 JAPAN DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 84 JAPAN DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 85 JAPAN DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 86 JAPAN DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 87 CHINA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 88 CHINA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 89 CHINA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 90 CHINA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 91 CHINA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 92 CHINA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 93 INDIA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 94 INDIA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 95 INDIA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 96 INDIA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 97 INDIA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 98 INDIA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 99 SOUTH KOREA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 100 SOUTH KOREA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 101 SOUTH KOREA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 102 SOUTH KOREA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 103 SOUTH KOREA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 104 SOUTH KOREA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 105 INDONESIA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 106 INDONESIA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 107 INDONESIA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 108 INDONESIA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 109 INDONESIA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 110 INDONESIA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 111 MALAYSIA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 112 MALAYSIA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 113 MALAYSIA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 114 MALAYSIA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 115 MALAYSIA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 116 MALAYSIA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 117 AUSTRALIA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 118 AUSTRALIA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 119 AUSTRALIA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 120 AUSTRALIA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 121 AUSTRALIA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 122 AUSTRALIA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 123 SINGAPORE DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 124 SINGAPORE DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 125 SINGAPORE DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 126 SINGAPORE DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 127 SINGAPORE DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 128 SINGAPORE DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 129 REST OF ASIA PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 130 REST OF ASIA PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 131 REST OF ASIA PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 132 REST OF ASIA PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 133 REST OF ASIA PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 134 REST OF ASIA PACIFIC DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 135 SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 136 SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 137 SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 138 SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 139 SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 140 SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 141 BRAZIL DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 142 BRAZIL DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 143 BRAZIL DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 144 BRAZIL DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 145 BRAZIL DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 146 BRAZIL DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 147 ARGENTINA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 148 ARGENTINA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 149 ARGENTINA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 150 ARGENTINA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 151 ARGENTINA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 152 ARGENTINA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 153 REST OF SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 154 REST OF SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 155 REST OF SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 156 REST OF SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 157 REST OF SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 158 REST OF SOUTH AMERICA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 159 MIDDLE EAST & AFRICA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 160 MIDDLE EAST & AFRICA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 161 MIDDLE EAST & AFRICA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 162 MIDDLE EAST & AFRICA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 163 MIDDLE EAST & AFRICA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 164 MIDDLE EAST & AFRICA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 165 SOUTH AFRICA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 166 SOUTH AFRICA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 167 SOUTH AFRICA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 168 SOUTH AFRICA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 169 SOUTH AFRICA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 170 SOUTH AFRICA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 171 GCC COUNTRIES DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 172 GCC COUNTRIES DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 173 GCC COUNTRIES DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 174 GCC COUNTRIES DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 175 GCC COUNTRIES DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 176 GCC COUNTRIES DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 177 SAUDI ARABIA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 178 SAUDI ARABIA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 179 SAUDI ARABIA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 180 SAUDI ARABIA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 181 SAUDI ARABIA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 182 SAUDI ARABIA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 183 REST OF MIDDLE EAST AND AFRICA DECONGESTANT ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019–2035 (USD BILLION)
TABLE 184 REST OF MIDDLE EAST AND AFRICA DECONGESTANT ESTIMATES & FORECAST, BY FORMULATION, 2019–2035 (USD BILLION)
TABLE 185 REST OF MIDDLE EAST AND AFRICA DECONGESTANT ESTIMATES & FORECAST, BY CATEGORY, 2019–2035 (USD BILLION)
TABLE 186 REST OF MIDDLE EAST AND AFRICA DECONGESTANT ESTIMATES & FORECAST, BY APPLICATION, 2019–2035 (USD BILLION)
TABLE 187 REST OF MIDDLE EAST AND AFRICA DECONGESTANT ESTIMATES & FORECAST, BY AGE GROUP, 2019–2035 (USD BILLION)
TABLE 188 REST OF MIDDLE EAST AND AFRICA DECONGESTANT ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019–2035 (USD BILLION)
TABLE 189 PFIZER. COMPANY: PRODUCTS OFFERED
TABLE 190 CIPLA LTD. PRODUCTS OFFERED
TABLE 191 GLAXOSMITHKLINE (GSK)/ PANADOL : PRODUCTS OFFERED
TABLE 192 JOHNSON & JOHNSON: PRODUCTS OFFERED
TABLE 193 APTARGROUP, INC. COMPANY: PRODUCTS OFFERED
TABLE 194 PROCTOR & GAMBLE COMPANY PRODUCTS OFFERED
TABLE 195 RECKITT BENCKISER GROUP PLC CHEMICAL LTD: PRODUCTS OFFERED
TABLE 196 SANOFI: PRODUCTS OFFERED
TABLE 197 PERRIGO COMPANY PLC: PRODUCTS OFFERED
TABLE 198 DR. REDDY’S LABORATORIES: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL DECONGESTANT MARKET (BY REGION), 2024
FIGURE 2 PORTER'S FIVE FORCES ANALYSIS OF THE DECONGESTANT
FIGURE 3 GLOBAL DECONGESTANT MARKET, BY PRODUCT TYPE, 2024 (% SHARE)
FIGURE 4 GLOBAL DECONGESTANT MARKET, BY FORMULATION, 2024 (% SHARE)
FIGURE 5 GLOBAL DECONGESTANT MARKET, BY CATEGORY, 2024 (% SHARE)
FIGURE 6 GLOBAL DECONGESTANT MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 7 GLOBAL DECONGESTANT MARKET, BY AGE GROUP, 2024 (% SHARE)
FIGURE 8 GLOBAL DECONGESTANT MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
FIGURE 9 GLOBAL DECONGESTANT MARKET MAJOR PLAYERS MARKET SHARE ANALYSIS, 2024 (%)
FIGURE 10 PFIZER. COMPANY: SWOT ANALYSIS
FIGURE 11 CIPLA LTD. SWOT ANALYSIS
FIGURE 12 GLAXOSMITHKLINE (GSK)/ PANADOL : SWOT ANALYSIS
FIGURE 13 JOHNSON & JOHNSON: SWOT ANALYSIS
FIGURE 14 APTARGROUP, INC. COMPANY: SWOT ANALYSIS
FIGURE 15 PROCTOR & GAMBLE COMPANY SWOT ANALYSIS
FIGURE 16 RECKITT BENCKISER GROUP PLC CHEMICAL LTD: SWOT ANALYSIS
FIGURE 17 SANOFI: SWOT ANALYSIS
FIGURE 18 PERRIGO COMPANY PLC: SWOT ANALYSIS
FIGURE 19 DR. REDDY’S LABORATORIES: SWOT ANALYSIS